Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Emerald Health Therapeutics 'on the cutting edge' of new cannabis market

Chris Wagner, chief executive of Emerald Health Therapeutics Inc (CVE:EMH, OTCQX:EMHTF), tells Proactive's Andrew Scott they're a licensed producer by Health Canada to grow, sell and produce cannabis across the country.

''We're ramping up for what will be the largest adult use market in the world ... on October 17 of this year there are regulations and laws in Canada which will change and it will allow adult use''.

''Right now we're selling and producing product for medical purposes only''.

''There are no companies like Emerald anywhere outside of Canada .. so if you  want to invest in companies that are on the cutting edge of this brand new market you need to look at Canadian companies''.

''We've been able to raise a tremendous amount of capital, put together a fantastic team, develop new products  and we're way ahead of everybody else on the planet''.

''If you want to be involved in a new industry ... this is the place to be''.

Join our Crypto, Blockchain and Cannabis Telegram group here  
Meet Arix Bioscience Plc, Avacta Group Plc and Silence Therapeutics plc at our event, London , 04 October 2018. Register here »
View full EMH profile View Profile

Emerald Health Therapeutics Inc Timeline

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use